322 related articles for article (PubMed ID: 35714911)
1. New dawn for cancer cell death: Emerging role of lipid metabolism.
Zhang C; Zhu N; Li H; Gong Y; Gu J; Shi Y; Liao D; Wang W; Dai A; Qin L
Mol Metab; 2022 Sep; 63():101529. PubMed ID: 35714911
[TBL] [Abstract][Full Text] [Related]
2. Targeting dysregulated lipid metabolism in the tumor microenvironment.
Kim DH; Song NY; Yim H
Arch Pharm Res; 2023 Dec; 46(11-12):855-881. PubMed ID: 38060103
[TBL] [Abstract][Full Text] [Related]
3. Aberrant lipid metabolism as an emerging therapeutic strategy to target cancer stem cells.
Visweswaran M; Arfuso F; Warrier S; Dharmarajan A
Stem Cells; 2020 Jan; 38(1):6-14. PubMed ID: 31648395
[TBL] [Abstract][Full Text] [Related]
4. The role of lipid metabolic reprogramming in tumor microenvironment.
Yang K; Wang X; Song C; He Z; Wang R; Xu Y; Jiang G; Wan Y; Mei J; Mao W
Theranostics; 2023; 13(6):1774-1808. PubMed ID: 37064872
[TBL] [Abstract][Full Text] [Related]
5. Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.
Butler LM; Perone Y; Dehairs J; Lupien LE; de Laat V; Talebi A; Loda M; Kinlaw WB; Swinnen JV
Adv Drug Deliv Rev; 2020; 159():245-293. PubMed ID: 32711004
[TBL] [Abstract][Full Text] [Related]
6. Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy.
Wu Y; Pu X; Wang X; Xu M
Lipids Health Dis; 2024 Feb; 23(1):35. PubMed ID: 38302980
[TBL] [Abstract][Full Text] [Related]
7. Exosomes-regulated lipid metabolism in tumorigenesis and cancer progression.
Ye L; Li Y; Zhang S; Wang J; Lei B
Cytokine Growth Factor Rev; 2023 Oct; 73():27-39. PubMed ID: 37291031
[TBL] [Abstract][Full Text] [Related]
8. Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids.
Zaidi N; Lupien L; Kuemmerle NB; Kinlaw WB; Swinnen JV; Smans K
Prog Lipid Res; 2013 Oct; 52(4):585-9. PubMed ID: 24001676
[TBL] [Abstract][Full Text] [Related]
9. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics.
Jin HR; Wang J; Wang ZJ; Xi MJ; Xia BH; Deng K; Yang JL
J Hematol Oncol; 2023 Sep; 16(1):103. PubMed ID: 37700339
[TBL] [Abstract][Full Text] [Related]
10. Cancer cells differentially activate and thrive on de novo lipid synthesis pathways in a low-lipid environment.
Daniëls VW; Smans K; Royaux I; Chypre M; Swinnen JV; Zaidi N
PLoS One; 2014; 9(9):e106913. PubMed ID: 25215509
[TBL] [Abstract][Full Text] [Related]
11. Role of lipid metabolism in hepatocellular carcinoma.
Cheng Y; He J; Zuo B; He Y
Discov Oncol; 2024 Jun; 15(1):206. PubMed ID: 38833109
[TBL] [Abstract][Full Text] [Related]
12. Reprogramming of Lipid Metabolism in Cancer: New Insight into Pathogenesis and Therapeutic Strategies.
Saikia S; Ahmed F; Prajapati BG; Padma VV; Chorawala MR; Postwala HI; Bhattacharya S
Curr Pharm Biotechnol; 2023; 24(15):1847-1858. PubMed ID: 37069718
[TBL] [Abstract][Full Text] [Related]
13. Lipids and prostate cancer.
Suburu J; Chen YQ
Prostaglandins Other Lipid Mediat; 2012 May; 98(1-2):1-10. PubMed ID: 22503963
[TBL] [Abstract][Full Text] [Related]
14. Lipids in the tumor microenvironment: From cancer progression to treatment.
Corn KC; Windham MA; Rafat M
Prog Lipid Res; 2020 Nov; 80():101055. PubMed ID: 32791170
[TBL] [Abstract][Full Text] [Related]
15. Lipid desaturation - the next step in targeting lipogenesis in cancer?
Peck B; Schulze A
FEBS J; 2016 Aug; 283(15):2767-78. PubMed ID: 26881388
[TBL] [Abstract][Full Text] [Related]
16. Lipid metabolism reprogramming and its potential targets in cancer.
Cheng C; Geng F; Cheng X; Guo D
Cancer Commun (Lond); 2018 May; 38(1):27. PubMed ID: 29784041
[TBL] [Abstract][Full Text] [Related]
17. Targeting lipid metabolism of cancer cells: A promising therapeutic strategy for cancer.
Liu Q; Luo Q; Halim A; Song G
Cancer Lett; 2017 Aug; 401():39-45. PubMed ID: 28527945
[TBL] [Abstract][Full Text] [Related]
18. The central role of mitochondria in the relationship between dietary lipids and cancer progression.
Varela-López A; Vera-Ramírez L; Giampieri F; Navarro-Hortal MD; Forbes-Hernández TY; Battino M; Quiles JL
Semin Cancer Biol; 2021 Aug; 73():86-100. PubMed ID: 33434641
[TBL] [Abstract][Full Text] [Related]
19. Lipid metabolic reprogramming by hypoxia-inducible factor-1 in the hypoxic tumour microenvironment.
Seo J; Yun JE; Kim SJ; Chun YS
Pflugers Arch; 2022 Jun; 474(6):591-601. PubMed ID: 35348849
[TBL] [Abstract][Full Text] [Related]
20. Aberrant Lipid Metabolism in Cancer: Current Status and Emerging Therapeutic Perspectives.
Irshad R; Tabassum S; Husain M
Curr Top Med Chem; 2023; 23(12):1090-1103. PubMed ID: 37218199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
